FAA Protocol for Thromboembolic Disease

Apr 2014

Guidance is compiled and interpreted by professional pilots and physicians at FlightPhysical.com from the 2014 AME Guide page 238, FAA and FDA web data (www.FAA.gov & www.FDA.gov), instructions specified in the Aeronautical Information Manual, Federal Air Surgeon Bulletins from 1999-2015, and 14 CFR Part 61 and Part 67 (the FARs).

An applicant with a history of thromboembolic disease must submit the following if consideration for medical certification is desired:

  1. Hospital admission and discharge summary
  2. Current status report including:

    • Detailed family history of thromboembolic disease
    • Neoplastic workup, if clinically indicated
    • PT/PTT
    • Protein S & C
    • Leiden Factor V
    • If still anticoagulated with warfarin (Coumadin), submit all (no less than monthly) INRs from time of hospital discharge to present

Note: For applicants who are just beginning warfarin (Coumadin) treatment the following is required:

  • Minimum observation time of 6 weeks after initiation of warfarin therapy;
  • Must also meet any required observation time for the underlying condition; AND
  • 6 INRs, no more frequently than 1 per week

Related Pages:

This page discussed FAA Protocol for Thromboembolic Disease

Reminder: use FlightPhysical.com to familiarize yourself with aviation medical regulations and guidelines, but always discuss your specific situation with one or more AMEs before dedicating resources toward expensive clinical workups. Find an AME now